Episode 14: Part 1: Immunobullous disorder - Bullous pemphigoid Artwork

St John's DermAcademy Podcast

Our Podcasts are delivered to you by clinicians and academics at St John’s Institute of Dermatology and invited speakers. Our aim is to update you and share practical tips on how experts in their field diagnose and treat common dermatological conditions in our short episodes that you can easily listen to whilst on the go. Our podcasts are targeted at healthcare professionals including dermatology consultants, dermatology trainees, GPs and specialist nurses. Disclaimer: The information on our podcasts is based on the latest evidence and expert opinion at the time of recording. The information is for general purposes only and we cannot offer advice for specific patients. Equally, this information is geared towards healthcare professionals. Any member of the public or patients listening should not use this as advice to treat their own condition or others and should consult their own physician for any medical they may have.

All Episodes

St John's DermAcademy Podcast

Episode 14: Part 1: Immunobullous disorder - Bullous pemphigoid

June 07, 2024 • St John's DermAcademy • Episode 14

In this episode our host Dr Sarah Drummond speaks with Dr Thomas Tull about bullous pemphigoid:
• The clinical features and risk factors for developing bullous pemphigoid
• How to differentiate bullous pemphigoid from other subepidermal blistering disorders
• Management of bullous pemphigoid including:
o Preferred first and second line agents
o How and when to reduce treatment
o What to do in severe and refractory cases

Resources and further reading:
• European guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology, 2022 (updated) (https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.18220)
• British Association of Dermatologists’ guidelines for the management of bullous pemphigoid, 2012 (https://onlinelibrary.wiley.com/doi/full/10.1111/bjd.12072)

Disclosure:
Dr. Tull provides consultancy services for Argenx who market Efgartigimod, which has been referenced in Part 1 and 2 of this series.

Recorded date: 26 January 2024

Please visit our website https://www.stjohnsdermacademy.com/podcasts for episode notes and references.